RADIUM REVISITED: CLINICAL EXPERIENCES WITH A NOVEL ALPHA-EMITTING BONE-SEEKING RADIOPHARMACEUTICAL IN PATIENTS WITH SKELETAL METASTASES FROM PROSTATE AND BREAST CANCER

被引：0
|
作者：
Nilsson, S. [1 ]
Larsen, R. H. [2 ]
Bruland, O. S. [3 ]
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Algeta Inc, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
ANTICANCER RESEARCH | 2004年 / 24卷 / 5D期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3445 / 3446
页数：2
相关论文
共 50 条
  • [41] Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single centre experience
    Gazzilli, M.
    Durmo, R.
    Albano, D.
    Cerudelli, E.
    Panarotto, M.
    Cossalter, E.
    Bertagna, F.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S628 - S628
  • [42] Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium.
    Frantellizzi, Viviana
    Longo, Flavia
    Schinzari, Giovanni
    Liberatore, Mauro
    Pacilio, Massimiliano
    Bianco, Vincenzo
    Follacchio, Giulia Anna
    De Vincentis, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421
    Lara, Primo N., Jr.
    Ely, Benjamin
    Quinn, David I.
    Mack, Philip C.
    Tangen, Catherine
    Gertz, Erik
    Twardowski, Przemyslaw W.
    Goldkorn, Amir
    Hussain, Maha
    Vogelzang, Nicholas J.
    Thompson, Ian M.
    Van Loan, Marta D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04):
  • [44] IMPACT OF SKELETAL-RELATED EVENTS ON ANTI-TUMOR THERAPY PATTERN IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER
    Bhowmik, D.
    Shi, N.
    Manjelievskaia, J.
    Song, X.
    Vidito, S., I
    Intorcia, M.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [45] The prognostic significance of biochemical markers of bone metabolism in patients with bone metastases from solid tumors other than breast and prostate cancer
    Brown, JE
    Cook, RJ
    Major, P
    Lipton, A
    Lee, KA
    Zheng, M
    Hei, YJ
    Coleman, RE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1596 - 1596
  • [46] Zoledronic acid reduces the survival-adjusted cumulative incidence of radiotherapy to bone in patients with bone metastases from breast or prostate cancer
    Major, Pierre P.
    Cook, Richar J.
    Chen, Bee-Lian
    Zheng, Ming
    ANNALS OF ONCOLOGY, 2004, 15 : 124 - 124
  • [47] Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer
    Southcott, D.
    Awan, A.
    Ghate, K.
    Clemons, M.
    Fernandes, R.
    CURRENT ONCOLOGY, 2020, 27 (04) : 220 - 224
  • [48] To assess the clinical effect of radium 223 (Ra223) in patients with progressive symptomatic bone metastases on a background of metastatic castrate resistant prostate cancer (mCRPC).
    Hague, Christina J.
    Fisher, Charlotte
    Wylie, James
    Choudhury, Ananya
    Elliot, Tony
    Tran, Anna
    Coyle, Catherine
    Conroy, Ruth
    Logue, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [49] Safety of radium-223 dichloride (Ra-223) with docetaxel (D) in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium Study
    Morris, Michael J.
    Hammers, Hans J.
    Sweeney, Christopher
    Antonarakis, Emmanuel S.
    Cho, Steve Y.
    Pandit-Taskar, Neeta
    Jacene, Heather
    Bloma, Marianne
    Aksnes, Anne-Kirsti
    O'Bryan-Tear, C. Gillies
    Carrasquillo, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: Results from a prospective, multicenter study
    Cazzaniga, Marina E.
    Dogliotti, Luigi
    Cascinu, Stefano
    Barni, Sandro
    Labianca, Roberto
    Chiara, Silvana
    Conte, Pier Franco
    Gasparini, Giampietro
    Pasetto, Lara
    Torri, Valter
    ONCOLOGY, 2006, 71 (5-6) : 374 - 381
12345